Notably, although CPB2 (encoding TAFI) has been proposed as a candidate gene in chronic thromboembolic disease, no exclusive variants in CPB2 were identified among CTEPH cases, underscoring the complexity of fibrinolysis-related genetic contributions and the need for larger, harmonized cohorts. The gene discussed is CPB2; the disease is chronic thromboembolic pulmonary hypertension.